Insulet (PODD) Acquisitions (2022 - 2023)
Insulet (PODD) posted Acquisitions of $3.0 million for Q1 2023, down 88.46% on a QoQ basis from $26.0 million in Q1 2022, and down 88.46% year-over-year from $26.0 million in Q1 2022.
Insulet (PODD) Acquisitions (2022 - 2023) Analysis & Trends
Insulet's Acquisitions history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2023.
- Quarterly Acquisitions fell 88.46% year-over-year to $3.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $3.0 million (down 88.46% YoY) and the FY2023 annual result came in at $3.0 million, down 88.46% from the prior year.
- Acquisitions was $3.0 million for Q1 2023 at Insulet, down from $26.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $26.0 million in Q1 2022 and bottomed at $3.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 2.30 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -268.10 Mn |
| 10 | Insulet | 11.62 Bn | 11.14 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2022 | 26.00 Mn |